MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term marketable
securities
$251,657K
Cash and cash
equivalents
$120,495K
Trade receivables,
net of allowances
$59,786K
Prepaid expenses and
other current assets
$40,658K
Inventory
$12,868K
Total current assets
$485,464K
Deferred tax assets, net
$168,197K
Long-term marketable
securities
$160,270K
Strategic inventory
$11,094K
Other assets
$5,153K
Operating lease
right-of-use asset
$4,583K
Property and equipment,
net
$1,890K
Total assets
$836,651K
Total liabilities and
stockholders equity
$836,651K
Total stockholders
equity
$647,805K
Total liabilities
$188,846K
Treasury stock at cost
36,552 shares of common...
$966,586K
Additional paid-in capital
$968,600K
Total current
liabilities
$166,085K
Long-term accrued income
taxes payable
$15,176K
Long-term operating lease
liability
$5,023K
Long-term accrued
government rebates
$2,562K
Retained earnings
$643,387K
Accumulated other
comprehensive income (loss)
$2,264K
Common stock, par value
0.001 per share,...
$140K
Accrued and other
liabilities
$90,603K
Accounts payable
$40,444K
Accrued research and
development expenses
$33,954K
Short-term operating lease
liability
$1,084K
Back
Back
Balance Sheet
source: myfinsight.com
CORCEPT THERAPEUTICS INC (CORT)
CORCEPT THERAPEUTICS INC (CORT)